TRIDENT-1 study is enrolling patients with ROS1+ advanced NSCLC and NTRK+ advanced solid tumors. The registrational Phase 2 portion of TRIDENT-1 study is a multi-center trial evaluating repotrectinib ...
GlobalData on MSN
Zai Lab’s Augtyro receives NMPA approval for solid tumours in China
Zai Lab has received approval from China’s National Medical Products Administration (NMPA) for the supplemental new drug ...
NORTH CHARLESTON – Trident Medical Center plans to add three operating rooms, a cardiac catheterization lab and a behavioral health hospital over the next year. Combined, the investments will exceed ...
Becoming an authorized Matter 1.4 test lab, alongside our existing expertise in Z-Wave and Zigbee, underscores our dedication to supporting the broader industry with world-class testing services.” — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback